Schedule 13G ownership disclosure
SELLAS Life Sciences Group, Inc.
Security class unavailable · CUSIP: 81642T100
Event date: 2019-06-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-180113
- Form type
- SC 13G
- Filer
- Anson Funds Management LP
- CIK
- CIK 1491072
- Filed
- Jun 24, 2019
- Reporting period
- Jun 14, 2019
- Description
- Schedule 13G beneficial ownership